Media

WEBINARS

Drug Developments for Alzheimer’s Disease: Progress and Possibilities

We often hear about “dementia breakthroughs” in the news – new genes being discovered, new blood tests being developed, new drugs being tested. However, there remains no effective or accessible cure for dementia. This is of great frustration to people living with dementia, and their carers and loved ones. This seminar discusses cutting-edge developments in pharmacological treatments for Alzheimer's disease, with a focus on recent clinical trial results. Our experts also talk about dementia prevention and risk reduction strategies. Facilitated by A/Prof Yen Ying Lim, this scientific seminar include talks by leading medical doctors and researchers with specialised interest in Alzheimer's disease, including Professor Amy Brodtmann, Professor Scott Ayton, and Dr Anita Goh, followed by a 40-minute long question and answer panel. Click Here to view the seminar.

Building Better Brains: A Dementia Prevention and Risk Reduction Seminar

An initiative of the BetterBrains research trial, this seminar included presentations and a Q&A panel with leading dementia & ageing experts, offering a behind the scenes look at the science of ageing well. In the absence of an effective or accessible cure for Alzheimer's disease dementia, many scientists have focused their efforts on what can be done to prevent dementia, and whether there are any factors that are associated with reducing the risk of developing dementia in the future. This seminar discussed cutting-edge research in the field of dementia prevention and risk reduction, with a focus on the everyday activities that we are able to change by making sustainable efforts to improve our lifestyles by exercising more, sleeping better, remaining cognitively and socially engaged, and eating healthier food. Click here to view the seminar.

PODCASTS

How new Alzheimer’s drugs slow the disease - ABC News Daily

Almost 400-thousand Australians have dementia, so chances are you either have it or know someone who does. This week’s news that an experimental drug has been found to slow the advance of Alzheimer’s disease has raised hopes that sufferers could enjoy more good months. Associate Professor Yen Ying Lim, Turner Institute for Brain and Mental Health, Monash University discusses how the drug works and how soon patients here might have access to it. 

Healthy Ageing Podcast: Episode 6 - BetterBrains

Dr Des talks to Dr Emily Rosenich, who is a Postdoctoral Research Fellow in Neuropsychology at the Turner Institute for Brain and Mental Health at Monash University. Emily’s research, funded by the Alzheimer’s Association, investigates cardiovascular, lifestyle, and genetic contributors to cognitive decline and dementia. In addition to her scientific work, Emily is a passionate science communicator and advocate for women in science.